I would guess that IBM knows who has z/OS licenses. And what hardware they are on. And whether they try to stay current on z/OS software. So they likely did analysis of how many z/OS v2 licenses would be acquired by machine type. And how many they would likely lose if the customer would decide to "stay put", becoming back level and perhaps migrating to another platform rather than upgrade the hardware. I guess the z9 was the tipping point. I.e. they felt that it they required a post-z9 processor, they would have too many customers "hang tight" and possibly use the "must upgrade hardware" and the cost to do so argument in their decision to continue using z/OS or convert.
In our case, as things now stand, this would be the final nail in the z/OS coffin. We have already dropped support on every product that we can continue to run without a support contract (two vendors - BMC & Compuware). When we either cannot run the next z/OS release/version or cannot run those products without renewing support, I am fairly sure we will just decide to stabilize on the current z/OS release and plan on a slow conversion to MS-Windows. We own our z9BC. IBM no longer allows any upgrades on this processor. The chances of us getting a current machine depends quite a bit on the US Supreme Court's decision on "Obamacare", especially the 80:20 rule. Which has destroyed our profitability. We basically cannot run the company on only 20% of our policy income. Especially since software costs just keep increasing, even when we don't really need any upgrades to continue running. We are just so 80s in the way we do things on the z. The only "new" things we do are: use XML f! or some data we share with "Open Systems" and TCPIP access to CICS (but not much). -- John McKown Systems Engineer IV IT Administrative Services Group HealthMarkets® 9151 Boulevard 26 • N. Richland Hills • TX 76010 (817) 255-3225 phone • john.mck...@healthmarkets.com • www.HealthMarkets.com Confidentiality Notice: This e-mail message may contain confidential or proprietary information. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message. HealthMarkets® is the brand name for products underwritten and issued by the insurance subsidiaries of HealthMarkets, Inc. –The Chesapeake Life Insurance Company®, Mid-West National Life Insurance Company of TennesseeSM and The MEGA Life and Health Insurance Company.SM > -----Original Message----- > From: IBM Mainframe Discussion List > [mailto:IBM-MAIN@bama.ua.edu] On Behalf Of R.S. > Sent: Thursday, April 12, 2012 12:26 PM > To: IBM-MAIN@bama.ua.edu > Subject: Re: Modernizing the BCP code ? > > W dniu 2012-04-12 18:52, McKown, John pisze: > > Apparently pre-z9 processors will not be able to IPL z/OS version 2 > > at all. I would guess a hard wait at IPL/NIP time. > > > > I'm curious: how much politics influenced on that decision? > > As far as I know, z9 wasn't so revolutionary generation. > A big change was introduced with z/990 and later with z10. > > So, I suspect it was political decision whether to support > z/990 and z9. > And someone sad no to z/990 and yes to z9. > > My €0.02 > -- > Radoslaw Skorupka > Lodz, Poland > > > > > -- > Tre tej wiadomoci moe zawiera informacje prawnie > chronione Banku przeznaczone wycznie do uytku subowego > adresata. Odbiorc moe by jedynie jej adresat z wyczeniem > dostpu osób trzecich. Jeeli nie jeste adresatem niniejszej > wiadomoci lub pracownikiem upowanionym do jej przekazania > adresatowi, informujemy, e jej rozpowszechnianie, > kopiowanie, rozprowadzanie lub inne dziaanie o podobnym > charakterze jest prawnie zabronione i moe by karalne. > Jeeli otrzymae t wiadomo omykowo, prosimy niezwocznie > zawiadomi nadawc wysyajc odpowied oraz trwale usun t > wiadomo wczajc w to wszelkie jej kopie wydrukowane lub > zapisane na dysku. > > This e-mail may contain legally privileged information of the > Bank and is intended solely for business use of the > addressee. This e-mail may only be received by the addressee > and may not be disclosed to any third parties. If you are not > the intended addressee of this e-mail or the employee > authorised to forward it to the addressee, be advised that > any dissemination, copying, distribution or any other similar > activity is legally prohibited and may be punishable. If you > received this e-mail by mistake please advise the sender > immediately by using the reply facility in your e-mail > software and delete permanently this e-mail including any > copies of it either printed or saved to hard drive. > > BRE Bank SA, 00-950 Warszawa, ul. Senatorska 18, tel. +48 > (22) 829 00 00, fax +48 (22) 829 00 33, www.brebank.pl, > e-mail: i...@brebank.pl > Sd Rejonowy dla m. st. Warszawy XII Wydzia Gospodarczy > Krajowego Rejestru Sdowego, nr rejestru przedsibiorców KRS > 0000025237, NIP: 526-021-50-88. > Wedug stanu na dzie 01.01.2012 r. kapita zakadowy BRE > Banku SA (w caoci wpacony) wynosi 168.410.984 zotych. > > ---------------------------------------------------------------------- > For IBM-MAIN subscribe / signoff / archive access instructions, > send email to lists...@bama.ua.edu with the message: INFO IBM-MAIN > > ---------------------------------------------------------------------- For IBM-MAIN subscribe / signoff / archive access instructions, send email to lists...@bama.ua.edu with the message: INFO IBM-MAIN
